Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLC Systems -- Ignore unavailable to you. Want to Upgrade?

To: Mark J Trudeau who wrote (721)	4/26/1998 10:55:00 PM
From: Charger	Read Replies (1) \| Respond to of 1202

Yes, am thinking the same, in fact some guesses are $22 at open, I dunno, but certainly anything lower than that would be a good move. I have heard some knowledgeable major shareholder investors saying the stock will seee $40-$50 this year. I have no idea but I do trust the experience of these people and will be watching (and holding). Exciting, huh! Charger

To: Mark J Trudeau who wrote (721)	4/27/1998 3:31:00 PM
From: ctirry	Respond to of 1202

I realize your post is now ancient by SI standards-it was posted yesterday but I just read it now. First I don't agree that there is nowhere to go but up-there is always down. Your comment that one could not get PLC for less than 20 is already proven wrong. With all the euphoria, PLC has a number of problems- 1) competition-obviously doing the procedure percutaneously is easier than PLC's method 2) there are a limited # of patients who will qualify for the procedure 3) there will be limits as to what HMO's as well as hospitals(who are now often in risk sharing arrangements) will pay for the procedure (I presently have no position in PLC)